Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$913M |
| 2 |
Meta Platforms (Facebook)
META
|
+$659M |
| 3 |
Caterpillar
CAT
|
+$450M |
| 4 |
PayPal
PYPL
|
+$435M |
| 5 |
Becton Dickinson
BDX
|
+$348M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$860M |
| 2 |
Humana
HUM
|
+$581M |
| 3 |
Goldman Sachs
GS
|
+$372M |
| 4 |
Boston Scientific
BSX
|
+$345M |
| 5 |
Walmart Inc
WMT
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.36% |
| 2 | Healthcare | 2.87% |
| 3 | Financials | 2.57% |
| 4 | Consumer Discretionary | 2.23% |
| 5 | Industrials | 2.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Nu Holdings
NU
$73.6B
| $13.3M | ﹤0.01% |
3,273,484
-2,596,765
| -44% | -$11.3M |
|
2377
Arcus Biosciences
RCUS
$3.75B
| $13.3M | ﹤0.01% |
643,229
+616,739
| +2,328% | +$17M |
|
2378
CALL
Celanese
CE
$5.01B
| $13.3M | ﹤0.01% |
130,000
+13,100
| +11% | +$1.3M |
|
2379
PUT
Ecolab
ECL
$77.4B
| $13.3M | ﹤0.01% |
91,300
-40,000
| -30% | -$5.88M |
|
2380
PUT
Gartner
IT
$11.4B
| $13.3M | ﹤0.01% |
39,500
-53,500
| -58% | -$17.3M |
|
2381
PUT
Matador Resources
MTDR
$6.64B
| $13.3M | ﹤0.01% |
231,700
+61,100
| +36% | +$3.85M |
|
2382
PUT
Royal Gold
RGLD
$19.5B
| $13.2M | ﹤0.01% |
117,400
-246,100
| -68% | -$25.4M |
|
2383
CALL
Invesco Solar ETF
TAN
$1.36B
| $13.2M | ﹤0.01% |
181,400
-110,600
| -38% | -$8.33M |
|
2384
CALL
Alerian MLP ETF
AMLP
$13.2B
| $13.2M | ﹤0.01% |
347,100
+64,000
| +23% | +$2.52M |
|
2385
SM Energy
SM
$8.03B
| $13.2M | ﹤0.01% |
378,702
+132,590
| +54% | +$5.51M |
|
|
EXAS
2386
CALL
DELISTED
Exact Sciences
EXAS
| $13.2M | ﹤0.01% |
265,800
-89,600
| -25% | -$3.66M |
|
|
LAC
2387
CALL
DELISTED
Lithium Americas Corp. Common Shares
LAC
| $13.1M | ﹤0.01% |
692,900
+387,800
| +127% | +$9.41M |
|
2388
ATI
ATI
$31.1B
| $13.1M | ﹤0.01% |
439,434
-388,723
| -47% | -$11.4M |
|
2389
PUT
Nutanix
NTNX
$18B
| $13.1M | ﹤0.01% |
503,500
+38,100
| +8% | +$1.04M |
|
2390
Broadstone Net Lease
BNL
$4.38B
| $13.1M | ﹤0.01% |
808,815
+67,811
| +9% | +$1.13M |
|
2391
PUT
NovoCure
NVCR
$1.97B
| $13.1M | ﹤0.01% |
178,200
+22,300
| +14% | +$1.68M |
|
2392
CALL
Carvana
CVNA
$83.1B
| $13.1M | ﹤0.01% |
13,784,000
-2,104,500
| -13% | -$4.44M |
|
2393
Veracyte
VCYT
$3.32B
| $13.1M | ﹤0.01% |
550,484
+144,559
| +36% | +$3.36M |
|
2394
Innoviva
INVA
$1.53B
| $13.1M | ﹤0.01% |
985,539
+147,595
| +18% | +$1.94M |
|
2395
PUT
H&R Block
HRB
$6.83B
| $13M | ﹤0.01% |
356,700
-103,100
| -22% | -$4.19M |
|
2396
Kimbell Royalty Partners
KRP
$1.52B
| $13M | ﹤0.01% |
779,321
+450,080
| +137% | +$7.91M |
|
2397
CALL
PureCycle Technologies
PCT
$1.4B
| $13M | ﹤0.01% |
1,920,400
+730,600
| +61% | +$5.27M |
|
2398
Castle Biosciences
CSTL
$905M
| $13M | ﹤0.01% |
551,315
-181,340
| -25% | -$4.2M |
|
2399
Assurant
AIZ
$13.9B
| $13M | ﹤0.01% |
103,768
+101,365
| +4,218% | +$13.5M |
|
2400
CALL
Signet Jewelers
SIG
$3.52B
| $12.9M | ﹤0.01% |
190,400
-86,100
| -31% | -$5.48M |
|
Similar funds
Ken Griffin's Q4 2022 Portfolio in Review
As of Q4 2022, Ken Griffin held 16,128 positions worth $428B, down 2.4% from $439B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin withdrew a net $22.3B in Q4 2022, closing 1,312 positions and reducing 5,802 holdings. Its most notable exit was Twitter, Inc., an estimated $297M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.4% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Ken Griffin opened a new position in Denbury Inc. worth $107M.
- Ken Griffin's largest Q4 2022 buy was Denbury Inc.: 1,228,903 shares worth $107M.
- Ken Griffin added most to Tesla in Q4 2022, an estimated $913M increase.
- Ken Griffin's biggest Q4 2022 reduction was Amazon, cutting an estimated $860M.
- Ken Griffin fully exited Twitter, Inc. in Q4 2022, selling an estimated $297M.
- Ken Griffin's ten largest holdings make up 28% of its $428B portfolio in Q4 2022.
- Ken Griffin opened 3,614 new positions and closed 1,312 in Q4 2022.
- Ken Griffin's portfolio value fell 2.4% quarter-over-quarter to $428B.
Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.